#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Soft tissue necrosis Retinopathy of prematurity Breast angiosarcoma Hodgkin's disease refractory Rhabdomyosarcoma Antisynthetase syndrome Subdural haematoma Malignant oligodendroglioma Precursor T-lymphoblastic lymphoma/leukaemia recurrent Chronic inflammatory demyelinating polyradiculoneuropathy Hereditary haemorrhagic telangiectasia Basal cell naevus syndrome Acute graft versus host disease in liver Mucopolysaccharidosis I Myasthenia gravis More trials…

    Learn about Rare Diseases

    Pulmonary sarcoidosis – Basic Information Rhabdoid tumour Thrombotic thrombocytopenic purpura – Life with Disease Primary hyperoxaluria – Life with Disease Aicardi-Goutieres syndrome – Basic Information Mucopolysaccharidosis II – Life with Disease Hereditary angioedema with C1 esterase inhibitor deficiency Rhabdoid tumour – Diagnostics Testicular leiomyosarcoma Anaplastic thyroid cancer – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mva-209-Fsp-B2 Carbamazepine (Ph. Eur.) Pervi-Neo Heterodimeric Interleukin-15 Oxybuprocaine Specific Nucleic Acid Sna-Xfsc ACARBOSE Gsk4527226 Etrasimod Arginine LUNRESERTIB Spartalizumab Doxribtimine Bi-1808 Oregovomab Dotatate Prasugrel Epoetin Alfa Anhydrous Cholestyramine Ecoo1A Valine More therapies…

    Learn about Your Condition

    Erythema migrans Hot flush Malabsorption Brain abscess Benign renal neoplasm Retinal vein occlusion Eructation Insulin resistance Bacterial vaginosis Naevoid melanoma Oesophageal atresia Gastrooesophageal cancer Alcoholism Dermatomyositis Liposarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Theageneio Cancer Hospital

Theageneio Cancer Hospital

Simeonidi Alex 2, Thessaloniki, 546 39, Greece

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Alectinib and Platinum-Based Chemotherapy for Patients with Resected Stage Ib to IIIa ALK-Positive Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Anaplastic lymphoma kinase gene mutation
    • Non-small cell lung cancer
    Investigated Drugs:
    • Alectinib
    • Vinorelbine
    • Carboplatin
    Austria Denmark France Germany Greece Hungary +4

  • Study of RO7247669, Tiragolumab, and Atezolizumab for Patients with Untreated Advanced Urothelial Cancer Ineligible for Platinum Chemotherapy

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Ro7247669
    • Atezolizumab
    • Tiragolumab
    Denmark France Germany Greece Italy Poland +1

  • Study on Bendamustine, Rituximab, and Acalabrutinib for Patients with Untreated Mantle Cell Lymphoma

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Acalabrutinib
    • Bendamustine Hydrochloride
    • Rituximab
    Belgium Czechia France Germany Greece Hungary +3

  • Study on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Crohn’s Disease

    Not recruiting

    3 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Risankizumab
    Austria Belgium Bulgaria Croatia Czechia Denmark +16

  • Study Comparing SGN-B6A and Docetaxel for Adults with Previously Treated Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • SIGVOTATUG VEDOTIN
    • Docetaxel
    Austria Belgium Czechia France Germany Greece +7

  • Study Comparing Venetoclax and Dexamethasone with Pomalidomide and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Betamethasone Sodium Phosphate Ph. Eur
    • Pomalidomide
    • Venetoclax
    Czechia Denmark France Germany Greece Italy +1

  • Study Comparing Repotrectinib and Crizotinib for Patients with Advanced or Metastatic ROS1-positive Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage IIIB
    • Non-small cell lung cancer
    Investigated Drugs:
    • Crizotinib
    • Repotrectinib
    Austria France Germany Greece Hungary Italy +4

  • Study Comparing Nivolumab to Placebo for Patients with High-Risk Invasive Bladder Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Transitional cell carcinoma
    Investigated Drugs:
    • Nivolumab
    Austria Belgium Denmark France Germany Greece +7

  • Study on Iberdomide for Maintenance Therapy in Patients with Newly Diagnosed Multiple Myeloma After Stem Cell Transplantation

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Iberdomide
    France Greece Italy The Netherlands

  • Study of Isatuximab with Lenalidomide and Dexamethasone for Elderly Patients (70+) with Newly Diagnosed Multiple Myeloma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Isatuximab
    Austria Greece
Previous Page
1 … 6 7 8 9
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!